A Study of AK104 in Subjects With Locally Advanced Unresectable or Metastatic MSI-H/dMMR Solid Tumors
Clinical trial NCT04547101 · TERMINATED
Trial details
- NCT number
- NCT04547101
- Sponsor
- Akeso
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-24
- Primary completion
- 2022-09-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.